Clinical trial
Glulisine Pre- and Postmeal
NCT00290043 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00290043 |
|---|---|
| Title | Glulisine Pre- and Postmeal |
| Official title | Glucodynamic Response to Pre- and Postmeal Subcutaneous Injection of 0.15 IU/kg HMR1964 Insulin and RHI in Type 1 Diabetic Subjects in an Open, Randomized, Four-way Crossover Study |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus Type 1 |
| Intervention type | Drug |
| Interventions | Insulin glulisine |
| Enrollment | 20 |
| Start date | Dec 1, 2001 |
| Completion | Mar 1, 2002 |
| First posted | Feb 10, 2006 |
| Last update posted | Dec 6, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: